Michigan Medicine researchers have been awarded approximately $10.2 million by the National Institutes of Health (NIH) Autoimmunity Centers of Excellence to explore potential treatments for autoimmune diseases, including scleroderma.
Funded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH, the grant will be used to develop three projects that are expected to find new therapies for scleroderma, lupus, rheumatoid arthritis, and other autoimmune disorders.
“As a NIH Autoimmunity Center of Excellence site, we have the opportunity at Michigan Medicine to conduct extensive translational research, in a clinical trial setting, on autoimmune diseases which allows us to provide the newest, targeted and personalized therapies to our patients,” Dinesh Khanna, MD, said in a press release. Khanna is professor of rheumatology and director of the Michigan Medicine Scleroderma Program.
Khanna will evaluate the potential use of the